Tokyo

London

New York

Register

Sign In

EUR/USD

1.0782

-0.0009

-0.08%

GBP/USD

1.2518

0.0044

0.35%

USD/JPY

111.00

-0.3715

-0.33%

USD/CHF

0.9932

0.0010

0.10%

EUR/GBP

0.8613

-0.0038

-0.44%

USD/CAD

1.3353

0.0020

0.15%

NZD/USD

0.7033

-0.0006

-0.09%

EUR/JPY

119.68

-0.4985

-0.41%

EUR/CHF

1.0709

0.0003

0.03%

Cerulean Pharma Inc.

NASDAQ: CERUHealthcare / Biotechnology / USA
0.74-0.38-33.93%Vol 10 245 0411Y Perf -74.20%
Mar 23rd, 2017 16:00
BID0.71 ASK0.72
Open0.87 Previous Close1.12
Pre-Market1.08 After-Trading0.70
 -0.04 -3.57%  -0.04 -5.41%
Target Price
1.50 
Analyst Rating
Moderate Buy 2.33
Potencial %
102.70 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)31 
Earnings Rating
Price Range Ratio 52wk %
2.97 
Earnings Date
23rd Mar 2017

Today's Price Range

0.700.90

 

52wk Range

0.634.33

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
5.33%
3 Months
-13.19%
6 Months
-71.17%
1 Year
-74.20%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CERU0.74-0.3800-33.93
AAPL140.92-0.5000-0.35
GOOG817.58-12.0100-1.45
MSFT64.87-0.1600-0.25
XOM81.860.10000.12
WFC55.25-0.0800-0.14
JNJ125.90-0.3600-0.29
FB139.53-0.0600-0.04
GE29.620.09000.30
JPM87.39-0.1400-0.16
...

TickerPriceChg.%52 Week High
PVH98.558.48115.40
TRIP42.522.7171.69
COG22.852.7026.74
NKE55.372.6962.64
AAL41.412.6350.64
SWN7.542.4515.59
HBAN13.021.8814.74
CHK5.091.808.20
KORS37.231.7858.63
SLG107.561.75120.63
DD80.561.7481.86
WDC76.191.6881.67
DOW63.831.6664.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.50
Current Ratio 2.50
Long Term Debt to Total Capital 0.28
Total Debt to Equity 0.89
Interest Coverage -17.20
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.48
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.80
Cash Flow Per Share -1.46
Price to Tangible Book5.48
Book Value per Share0.61
Enterprise Value (in ths.)67 771
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -119.76
Return on Assets (5Y Avg) -
ROA last 12 Months -74.96
Return on Capital (5Y Avg) -
ROC last 12 Months -81.61
Return on invested Capital Q -25.62
Return on invested Capital Y-57.11
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-0.43-0.3616.28
Q02 2016-0.48-0.4016.67
Q01 2016-0.42-0.49-16.67
Q04 2015-0.38-0.39-2.63
Q03 2015-0.38-0.39-2.63
Q02 2015-0.40-0.377.50
Q01 2015-0.45-0.418.89
Q04 2014-0.36-0.37-2.78
Earnings Per EndEstimateRevision %Trend
12/2016 QR-0.3014.29Positive
12/2016 FY-1.601.23Positive
3/2017 QR-0.310.00-
12/2017 FY-1.42-29.09Negative
Next Report Date23rd Mar 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %0.00
Volume Overview
Volume10 245 041
Shares Outstanding (in ths.)27 440
Trades Count8 456
Dollar Volume7 478 335
Avg. Volume4 084 295
Avg. Weekly Volume12 050 222
Avg. Monthly Volume7 674 185
Avg. Quarterly Volume3 844 424

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

42%58%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1
1
2
Moderate Buy
0
0
0
Hold
2
2
3
Moderate Sell
0
0
0
Strong Sell
0
0
0
RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.20

There are no comments yet.

News

Plus500
x